Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Refer to the last post. Please provide proof.
VLDI is worth .026 a share right now. I am looking at the stock price. If you have any proof it is worth some other value then please share with us. If you have a demo of the software or technology then please share with us. if you have proof a paying or non-paying client is using the technology or software please share with us. if you have proof of a buyout in the works then please share with us.
I am no expert trader, but when someone tells me a .025 stock is going to be worth double digit dollars - BIG RED FLAG
Yeah, I just HATE IT when I get the opportunity to buy a stock for less than 3 cents that will eventually be trading in double-digit dollars, don't you?
You are missing out on a great opportunity to make a fortune.
you are down 50% in the past 3 months.. it sure sounds like you should have...
Based on how this has been trading the past few weeks it appears Surwin is right... Timmmmmmmmmmmmmmber
wow - bloodbath this morning. This might be headed back into the sub-penny range without any meaningful news soon.
Pay close attention to this last PR on Feb 23rd - I highlighted some important sentences with near-term events.
BioCorRx Provides Preclinical Study Update on BICX101 Development
ANAHEIM, CA / ACCESSWIRE / February 23, 2017 / BioCorRx Inc. (OTC PINK: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today provided an update on the preclinical development of BICX101, a new sustained release injectable naltrexone product for the treatment of substance abuse addiction, via a webcast that is available on the News & Media section ("Presentation" subpage) of the Company's website: www.BioCorRx.com.
Brady Granier, President, CEO and Director, stated, "We're very excited about the preclinical studies thus far." He further stated that the company anticipates submitting a request for a Pre-IND meeting with the FDA sometime in the middle of March with the actual meeting anticipated to take place within 60 days from that request.
Dr. Balbir S. Brar, VP of Drug Development, commented, "We have screened a number of formulations that were produced by TheraKine and these formulations were tested in two phases of preclinical studies." He added, "We have selected a lead formulation which is very promising and will be tested in a number of variations in additional studies to be started very shortly. So far, the results are consistent with our goals." Brar also mentioned that the company hopes to complete the preclinical studies in 5 to 6 weeks and gain clearance for a 505(b)(2) 'fast-track' regulatory pathway which can shorten or even eliminate phases of the approval process. Dr. Brar provided a more detailed update on the Company's preclinical and regulatory activities in the webcast.
Dr. David Gastfriend, Medical Consultant to BioCorRx stated, "There is a market that has emerged. It is being developed and this desire to use injectable naltrexone has become established throughout the country. An improved formulation is a valuable addition to the medical armamentarium." In the webcast, Dr. Gastfriend discusses a number of additional anticipated benefits of BICX101 over the current approved products on the market.
VLDI has been in operation for 15+ years. It's not a startup.
The stock goes down on heavy volume and his manipulation... if the stock goes up then it must be news is coming... lol
The broken record plays on and on and on and on....
Huge selling going on today. If the 360K bid at .026 gets whacked who know how low this will go...
I have a feeling we're going to see a lot of green these days. We have an FDA update coming soon
Great week for BICX. I say high teens for next week and any positive news then sky's the limit.
TA is gagged so we will never know.
VFIN on the offer - not good.
Has anyone reached out to the company and asked what the next steps are?
we are on the big boys radar now! here comes the money$$$$
We have tons of accumulation going in the .09's so investors are expected a pop. Any positive FDA news should send bicx into the teens.
I am just going hold at this point. They still have plenty of cash so I am sure they are hashing out a plan as we speak. I guess they don't have to take the recommendation. Has any company still been approved by the FDA after an recommendation to stop the trial?
Sorry Willy the presentation is under NDA
Demo? LOL
I heard a rumor CEO Brady Granier has a meeting with President Trumps' people to discuss..
there is no pre-market on the OTC so those are only market maker trades to settle up from the day before. no significance whatsoever
What are your thoughts Austin? Anything left here?
We are due for a PR soon and it better be something with progress.
haha - those investor conferences are exactly that - a magic show. A contract with a legitimate company is the only thing that will move the stock.
any decent sized bids smashed as usual...smh
Paper company! Could make one online for a couple hundred bucks. Maybe Surwin mobile
2011 "soon"
2012 "soon"
2013 "soon"
2014 "soon"
2015 "soon"
2016 "soon"
Take a guess for 2017???
No news that I have heard of. Maybe investors seeing the value and loading up. I have been seeing increased press out there on the company and updates to the website.
.08's getting hit with decent volume!
We all know what news is coming.... status quo
.03 just broke! Sub Penny here we come
Any hope for this one or is it going to zero?
Stock is really struggling to stay above .03. Any decent bids whacked
Mostly bid whacks today.
I wouldn't really call 5% a huge dip. Lol
That was probably a T Trade. It's when a market maker trades shares during the day, but doesn't print it until after the close. Google it.
I think the author is just comparing them to other companies in the addiction space. Remember, always look at a companies' market cap for the value and not the stock price.
Volume picking up and price is holding nice in the mid .06's